olprinone has been researched along with mocetinostat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Hagiwara, S; Iwasaka, H; Kira, S; Kitano, T; Miyakawa, H; Noguchi, T; Oishi, K | 1 |
| Goto, K; Hattori, S; Kira, S; Kudo, K; Mizutani, A; Mizutani, S; Murakami, K; Noguchi, T; Okajima, K; Takatani, J | 1 |
3 other study(ies) available for olprinone and mocetinostat
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Olprinone improves diaphragmatic contractility and fatigability during abdominal sepsis in a rat model.
Topics: Abdomen; Analysis of Variance; Animals; Cardiotonic Agents; Cecum; Diaphragm; Disease Models, Animal; Imidazoles; Injections, Intraperitoneal; Male; Muscle Contraction; Muscle Fatigue; Neutrophil Activation; Peroxidase; Pyridones; Rats; Rats, Wistar; Sepsis | 2004 |
Olprinone reduces ischemia/reperfusion-induced acute renal injury in rats through enhancement of cAMP.
Topics: Animals; Blood Urea Nitrogen; Cardiotonic Agents; Creatinine; Cyclic AMP; Hemodynamics; Imidazoles; Inflammation; Interleukin-8; Kidney; Leukocytes; Lymphocyte Activation; Male; Necrosis; Neutrophils; Peroxidase; Phosphodiesterase Inhibitors; Pyridones; Rats; Rats, Wistar; Reperfusion Injury; Time Factors; Tumor Necrosis Factor-alpha | 2005 |